Cargando…

Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial

BACKGROUND: Low adherence to chronic kidney disease (CKD) guidelines may be due to unrecognized CKD and lack of guideline awareness on the part of providers. The goal of this study was to evaluate the impact of provider education and access to a CKD registry on guideline adherence. METHODS: We condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Drawz, Paul E, Miller, R Tyler, Singh, Simran, Watts, Brook, Kern, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556093/
https://www.ncbi.nlm.nih.gov/pubmed/22765882
http://dx.doi.org/10.1186/1472-6947-12-62
_version_ 1782257142886039552
author Drawz, Paul E
Miller, R Tyler
Singh, Simran
Watts, Brook
Kern, Elizabeth
author_facet Drawz, Paul E
Miller, R Tyler
Singh, Simran
Watts, Brook
Kern, Elizabeth
author_sort Drawz, Paul E
collection PubMed
description BACKGROUND: Low adherence to chronic kidney disease (CKD) guidelines may be due to unrecognized CKD and lack of guideline awareness on the part of providers. The goal of this study was to evaluate the impact of provider education and access to a CKD registry on guideline adherence. METHODS: We conducted a cluster randomized controlled trial at the Louis Stokes Cleveland VAMC. One of two primary care clinics was randomized to intervention. Providers from both clinics received a lecture on CKD guidelines at study initiation. Providers in the intervention clinic were given access to and shown how to use a CKD registry, which identifies patients with CKD and is automatically updated daily. Eligible patients had at least one primary care visit in the last year, had CKD based on eGFR, and had not received renal replacement therapy. The primary outcome was parathyroid hormone (PTH) adherence, defined by at least one PTH measurement during the 12 month study. Secondary outcomes were measurement of phosphorus, hemoglobin, proteinuria, achievement of goal blood pressure, and treatment with a diuretic or renin-angiotensin system blocker. RESULTS: There were 418 and 363 eligible patients seen during the study in the control and intervention clinics, respectively. Compared to pre-intervention, measurement of PTH increased in both clinics (control clinic: 16% to 23%; intervention clinic: 13% to 28%). Patients in the intervention clinic were more likely to have a PTH measured during the study (adjusted odds ratio = 1.53; 95% CI (1.01, 2.30); P = 0.04). However, the intervention was not associated with a consistent improvement in secondary outcomes. Only 5 of the 37 providers in the intervention clinic accessed the registry. CONCLUSIONS: An intervention that included education on CKD guidelines and access to a CKD patient registry marginally improved guideline adherence over education alone. Adherence to the primary process measure improved in both clinics, but no improvement was seen in intermediate clinical outcomes. Improving the care of patients with CKD will likely require a multifaceted approach including system redesign. CLINICALTRIALS.GOV REGISTRATION NUMBER: NCT00921687
format Online
Article
Text
id pubmed-3556093
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35560932013-01-31 Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial Drawz, Paul E Miller, R Tyler Singh, Simran Watts, Brook Kern, Elizabeth BMC Med Inform Decis Mak Research Article BACKGROUND: Low adherence to chronic kidney disease (CKD) guidelines may be due to unrecognized CKD and lack of guideline awareness on the part of providers. The goal of this study was to evaluate the impact of provider education and access to a CKD registry on guideline adherence. METHODS: We conducted a cluster randomized controlled trial at the Louis Stokes Cleveland VAMC. One of two primary care clinics was randomized to intervention. Providers from both clinics received a lecture on CKD guidelines at study initiation. Providers in the intervention clinic were given access to and shown how to use a CKD registry, which identifies patients with CKD and is automatically updated daily. Eligible patients had at least one primary care visit in the last year, had CKD based on eGFR, and had not received renal replacement therapy. The primary outcome was parathyroid hormone (PTH) adherence, defined by at least one PTH measurement during the 12 month study. Secondary outcomes were measurement of phosphorus, hemoglobin, proteinuria, achievement of goal blood pressure, and treatment with a diuretic or renin-angiotensin system blocker. RESULTS: There were 418 and 363 eligible patients seen during the study in the control and intervention clinics, respectively. Compared to pre-intervention, measurement of PTH increased in both clinics (control clinic: 16% to 23%; intervention clinic: 13% to 28%). Patients in the intervention clinic were more likely to have a PTH measured during the study (adjusted odds ratio = 1.53; 95% CI (1.01, 2.30); P = 0.04). However, the intervention was not associated with a consistent improvement in secondary outcomes. Only 5 of the 37 providers in the intervention clinic accessed the registry. CONCLUSIONS: An intervention that included education on CKD guidelines and access to a CKD patient registry marginally improved guideline adherence over education alone. Adherence to the primary process measure improved in both clinics, but no improvement was seen in intermediate clinical outcomes. Improving the care of patients with CKD will likely require a multifaceted approach including system redesign. CLINICALTRIALS.GOV REGISTRATION NUMBER: NCT00921687 BioMed Central 2012-07-05 /pmc/articles/PMC3556093/ /pubmed/22765882 http://dx.doi.org/10.1186/1472-6947-12-62 Text en Copyright ©2012 Drawz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Drawz, Paul E
Miller, R Tyler
Singh, Simran
Watts, Brook
Kern, Elizabeth
Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title_full Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title_fullStr Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title_full_unstemmed Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title_short Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
title_sort impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556093/
https://www.ncbi.nlm.nih.gov/pubmed/22765882
http://dx.doi.org/10.1186/1472-6947-12-62
work_keys_str_mv AT drawzpaule impactofachronickidneydiseaseregistryandprovidereducationonguidelineadherenceaclusterrandomizedcontrolledtrial
AT millerrtyler impactofachronickidneydiseaseregistryandprovidereducationonguidelineadherenceaclusterrandomizedcontrolledtrial
AT singhsimran impactofachronickidneydiseaseregistryandprovidereducationonguidelineadherenceaclusterrandomizedcontrolledtrial
AT wattsbrook impactofachronickidneydiseaseregistryandprovidereducationonguidelineadherenceaclusterrandomizedcontrolledtrial
AT kernelizabeth impactofachronickidneydiseaseregistryandprovidereducationonguidelineadherenceaclusterrandomizedcontrolledtrial